Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 260,941 | 260,710 | 287,133 | 340,522 | 342,485 |
| Marketable Securities | 41,242 | 50,378 | 59,005 | 20,385 | 20,381 |
| Receivables | 12,400 | 9,343 | 14,233 | 12,099 | 29,203 |
| Inventories | 6,262 | 5,710 | 3,591 | 2,897 | 3,344 |
| Other current assets | 24,873 | 21,786 | 13,969 | 15,617 | 15,321 |
| TOTAL | $345,718 | $347,927 | $377,931 | $391,520 | $410,734 |
| Non-Current Assets | |||||
| PPE Net | 64,071 | 52,653 | 36,811 | 23,712 | 16,762 |
| Intangibles | 1,074 | 1,071 | 1,094 | 1,108 | 1,120 |
| Other Non-Current Assets | 74,094 | 71,045 | 55,298 | 51,129 | 51,859 |
| TOTAL | $139,239 | $124,769 | $93,203 | $75,949 | $69,741 |
| Total Assets | $484,957 | $472,696 | $471,135 | $467,469 | $480,475 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 35,003 | 32,674 | 26,873 | 29,264 | 19,761 |
| Other current liabilities | 16,840 | 16,118 | 20,250 | 12,240 | 9,038 |
| TOTAL | $56,613 | $53,052 | $49,008 | $62,604 | $51,381 |
| Non-Current Liabilities | |||||
| Long Term Debt | 31,473 | 6,640 | 48,699 | N/A | 44,466 |
| Deferred Revenues | 440 | 483 | 543 | 20,033 | 19,586 |
| Other Non-Current Liabilities | 73,965 | 71,533 | 6,321 | 53,365 | 6,342 |
| TOTAL | $102,133 | $74,584 | $51,540 | $49,395 | $47,323 |
| Total Liabilities | $158,747 | $127,637 | $100,548 | $111,999 | $98,704 |
| Shareholders' Equity | |||||
| Common Shares | 2,768 | 2,768 | 2,767 | 2,767 | 2,766 |
| Retained earnings | -550,191 | -520,754 | -488,509 | -508,481 | -471,050 |
| Other shareholders' equity | 22,285 | 13,723 | 9,491 | 17,706 | 10,618 |
| TOTAL | $326,210 | $345,059 | $370,588 | $355,470 | $381,771 |
| Total Liabilities And Equity | $484,957 | $472,696 | $471,136 | $467,469 | $480,475 |